ENTITY
Pharmaessentia Corp

Pharmaessentia Corp (6446 TT)

124
Analysis
Health Care • Taiwan
PharmaEssentia Corporation develops and distributes therapeutic products for treatment in human disease. The Company develops drugs to treat hepatitis, chronic myeloid leukemia (CML), essential thrombocythemia (ET), myeloid fibrosis (MF), polycythemia vera (PV), hepatitis and cancer.
more
Company Event • 09 Nov 2026 12:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 12 Aug 2026 13:30 • Upcoming
Add To Calendar

Q2 2026

Company Event • 14 May 2026 06:00 • Upcoming
Add To Calendar

Q1 2026

Company Event • 27 Mar 2026 11:00 • Upcoming
Add To Calendar

Q4 2025

Company Event • 01 Dec 2025 11:00 • Upcoming
Add To Calendar

Q3 2025

x